Seixal, Portugal

Luis D Carvalho


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Luis D Carvalho

Introduction

Luis D Carvalho is a notable inventor based in Seixal, Portugal. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and treatment methods that utilize steroid compounds. His work aims to improve pharmaceutical formulations and address various health issues.

Latest Patents

Luis D Carvalho holds 1 patent for his invention titled "Pharmaceutical compositions and treatment methods." This invention provides compositions that include formula 1 steroids, such as 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate, along with one or more excipients. The compositions are designed to contain less than about 3% water, making them useful for creating improved pharmaceutical formulations. Additionally, the invention outlines methods for intermittent dosing of steroid compounds and compositions that can inhibit viral replication, ameliorate symptoms of immune dysregulation, and modulate immune responses in subjects.

Career Highlights

Luis D Carvalho is associated with Hollis-Eden Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative work in the pharmaceutical industry has the potential to impact various therapeutic areas significantly.

Collaborations

Throughout his career, Luis has collaborated with esteemed colleagues, including Clarence Nathaniel Ahlem and William Heggie. These collaborations have further enriched his research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Luis D Carvalho's contributions to the field of pharmaceuticals exemplify the importance of innovation in developing effective treatment methods. His work not only enhances pharmaceutical formulations but also addresses critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…